ESHA SACHDEV
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology LONG BEACH, CA NPI 1114260460
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology CA NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$5,423.83
- Category: General Payments
- Program years: PY2018–2024
- Record count: 141
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,403.19 across 51 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,304.20 | 50 |
| Education | $98.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $143.88 | 6 |
| Daiichi Sankyo Inc. | $142.89 | 3 |
| Alexion Pharmaceuticals, Inc. | $137.03 | 2 |
| PFIZER INC. | $116.92 | 6 |
| Celgene Corporation | $100.10 | 4 |
| Merck Sharp & Dohme Corporation | $95.92 | 4 |
| EISAI INC. | $70.10 | 3 |
| EMD Serono, Inc. | $62.47 | 2 |
| Gilead Sciences, Inc. | $55.25 | 2 |
| GlaxoSmithKline, LLC. | $52.42 | 2 |
| BeiGene USA, Inc. | $45.18 | 2 |
| AVEO Pharmaceuticals, Inc. | $35.42 | 1 |
| E.R. Squibb & Sons, L.L.C. | $33.74 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.56 | 1 |
| Acerta Pharma LLC | $32.52 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $28.09 | 1 |
| Stemline Therapeutics Inc. | $27.34 | 1 |
| Lilly USA, LLC | $26.80 | 1 |
| Karyopharm Therapeutics Inc. | $26.08 | 1 |
| SOBI, INC | $25.92 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $24.91 | 1 |
| Sumitomo Pharma America, Inc. | $23.61 | 1 |
| ABBVIE INC. | $22.85 | 1 |
| Janssen Biotech, Inc. | $22.44 | 1 |
| ARRAY BIOPHARMA INC | $18.75 | 1 |
By program year
Records — PY2024 (51)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.